2024-Ultrasound Utilization in Hospitalized Kidney Transplant Recipien…
페이지 정보
작성자 신호식 작성일25-01-06 08:39 조회571회 댓글0건첨부파일
관련링크
본문
2024-Ultrasound Utilization in Hospitalized Kidney Transplant Recipients
Kidney transplant ultrasonography is an important diagnostic tool in the care of transplant recipients. This modality of
nonradiation-based imaging allows for precise and expedient reporting of allograft architecture, which can inform clinical
decision-making. However, as with any diagnostic tool, overuse may lead to unnecessary interventions and costs on the healthcare
system. To better understand the use of ultrasonography in hospitalized kidney transplant recipients and outcomes of subsequent
interventions, we conducted a single-center retrospective study at a large transplant program in Ontario, Canada. We noted that
over 30% of admissions resulted in a ultrasonographic survey within the first 24 h of presentation; however, most of these did not
change clinical management or lead to a subsequent procedural intervention. Using multivariable logistic regression,we identified
predictors for receiving an ultrasound, including time from transplantation, elevated serum creatinine and infectious diagnosis.
Procedural interventions (e.g., drain or biopsy) resulted from less than 20% of all ultrasound investigations, with patients closer
to the time of index transplant or with elevated serum creatinine values more likely to receive an intervention. In conducting a
cost analysis, we estimated that approximately $80 000 CAD per year could be saved with more selective decisions on ultrasound
requisitions. Overall, our results indicate that despite being an informative tool, the broad use of ultrasonography in the kidney
transplant population may not yield significant changes to transplant care
Kidney transplant ultrasonography is an important diagnostic tool in the care of transplant recipients. This modality of
nonradiation-based imaging allows for precise and expedient reporting of allograft architecture, which can inform clinical
decision-making. However, as with any diagnostic tool, overuse may lead to unnecessary interventions and costs on the healthcare
system. To better understand the use of ultrasonography in hospitalized kidney transplant recipients and outcomes of subsequent
interventions, we conducted a single-center retrospective study at a large transplant program in Ontario, Canada. We noted that
over 30% of admissions resulted in a ultrasonographic survey within the first 24 h of presentation; however, most of these did not
change clinical management or lead to a subsequent procedural intervention. Using multivariable logistic regression,we identified
predictors for receiving an ultrasound, including time from transplantation, elevated serum creatinine and infectious diagnosis.
Procedural interventions (e.g., drain or biopsy) resulted from less than 20% of all ultrasound investigations, with patients closer
to the time of index transplant or with elevated serum creatinine values more likely to receive an intervention. In conducting a
cost analysis, we estimated that approximately $80 000 CAD per year could be saved with more selective decisions on ultrasound
requisitions. Overall, our results indicate that despite being an informative tool, the broad use of ultrasonography in the kidney
transplant population may not yield significant changes to transplant care



